VaxGen Receives $11M Consolation Prize
The U.S. government, which recently terminated an $877.5 million contract with VaxGen Inc., has agreed to pay the biotechnology company $11 million and not hold it liable for the excess costs...To view the full article, register now.
Already a subscriber? Click here to view full article